Form 4: SeaStar Medical Holding Corp: CEO Receives RSU Award
Statement of Changes in Beneficial Ownership
SeaStar Medical Holding Corp CEO Eric Schlorff was granted 10,288 restricted stock units, with vesting scheduled over the next two years.
Summary
- Eric Schlorff, Chief Executive Officer of SeaStar Medical Holding Corp, received an award of 10,288 restricted stock units (RSUs).
- The RSUs are scheduled to vest in three equal installments on July 1, 2026, November 1, 2026, and March 1, 2027.
- This transaction is reported under SEC Form 4, indicating a change in beneficial ownership.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it reports a standard executive equity award without providing new financial information or strategic updates.
Positives
- The CEO has been granted equity, which can align management's interests with shareholders.
- The RSU award is structured with future vesting dates, encouraging continued service and performance.
Risks
- The value of the RSUs is subject to the future performance of SeaStar Medical Holding Corp's stock price.
- Vesting is contingent on continued employment, meaning forfeiture is possible if the CEO departs before vesting dates.
Future Outlook
The filing does not contain forward-looking statements or guidance regarding future financial performance. It solely reports a transaction related to executive compensation.
Industry Context
StockSavvy.ai notes that equity awards to key executives are a common practice in the biotechnology and medical device sectors, aiming to retain talent and incentivize performance aligned with long-term company value.
Stakeholder Impact
- Shareholders: The RSU award aligns CEO incentives with long-term shareholder value, but the immediate impact on share price is negligible. Future performance will determine the ultimate value of these awards.
- Employees: The award to the CEO may be seen as a positive signal of management's commitment, but it does not directly impact other employees.
- Management: The CEO receives an incentive tied to company performance and continued service.
Next Steps
- Vesting of restricted stock units on July 1, 2026, November 1, 2026, and March 1, 2027, subject to continued employment.
Key Dates
| Date | Description |
|---|---|
| 07/01/2026 | First installment vesting date for RSUs. |
| 11/01/2026 | Second installment vesting date for RSUs. |
| 03/01/2027 | Third and final installment vesting date for RSUs. |
| 07/01/2026 | Earliest transaction date reported. |
| 07/02/2026 | Date of report signature. |
Keywords
SeaStar Medical Holding Corp, ICU, Form 4, Restricted Stock Units, RSU, Eric Schlorff, CEO, Beneficial Ownership, Equity Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.